[Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000209:etiology; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use*; D001748:Urinary Bladder Neck Obstruction / Q000188:drug therapy* / Q000209:etiology; D014563:Urodynamics / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D011799:Quinazolines; C047638:alfuzosin